Literature DB >> 17058141

Successful treatment of malignant pericardial effusion, using weekly paclitaxel, in a patient with breast cancer.

Takahiro Einama1, Kazuhiko Sato, Hitoshi Tsuda, Hidetaka Mochizuki.   

Abstract

We report a case of metastatic breast cancer with pericardial effusion that was successfully treated with weekly paclitaxel. A 46-year-old woman underwent modified radical mastectomy in April 1997 and was readmitted to the hospital for dyspnea in March 2002. A diagnosis of cardiac tamponade due to breast cancer relapse was made, and the patient was treated with weekly paclitaxel (80 mg/m2) and insertion of a drainage catheter. This treatment was effective in preventing reaccumulation of the pericardial effusion until her death. The concentration of paclitaxel in the cardiac effusion was 45 ng/ml at 3 h, 15 ng/ml at 12 h, and less than 10 ng/ml at 24 h after paclitaxel infusion, indicating good transportation of the drug from the blood to the pericardial effusion. These findings suggest that weekly intravenous infusion of paclitaxel could be effective for the treatment of patients with malignant pericardial effusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17058141     DOI: 10.1007/s10147-006-0593-2

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  20 in total

Review 1.  Neoplastic cardiac tamponade.

Authors:  A Theologides
Journal:  Semin Oncol       Date:  1978-06       Impact factor: 4.929

2.  Pericardial effusion in patients with cancer: outcome with contemporary management strategies.

Authors:  R J Laham; D J Cohen; R E Kuntz; D S Baim; B H Lorell; M Simons
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

3.  The management of cardiac tamponade in patients with breast cancer.

Authors:  J D Bitran; R Evans; C Brown
Journal:  J Surg Oncol       Date:  1984-09       Impact factor: 3.454

4.  Pericardiocentesis.

Authors:  J G Krikorian; E W Hancock
Journal:  Am J Med       Date:  1978-11       Impact factor: 4.965

5.  Pericardial effusions in patients with malignant diseases.

Authors:  E P Flannery; G Gregoratos; M P Corder
Journal:  Arch Intern Med       Date:  1975-07

6.  Management of acute cardiac tamponade by subxiphoid pericardiotomy.

Authors:  K E Alcan; P M Zabetakis; N D Marino; A J Franzone; M F Michelis; M S Bruno
Journal:  JAMA       Date:  1982-02-26       Impact factor: 56.272

7.  Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion.

Authors:  T Ohtsu; Y Sasaki; T Tamura; Y Miyata; H Nakanomyo; Y Nishiwaki; N Saijo
Journal:  Clin Cancer Res       Date:  1995-06       Impact factor: 12.531

8.  [Recurrent ovarian cancer with cancer peritonitis treated with weekly paclitaxel infusion--a clinicopharmacological study].

Authors:  Satoshi Urabe; Hisaya Fujiwara; Makiko Egawa; Naoya Fujitou; Tomohisa Sakashita; Kenjirou Date; Tomoya Mizunoe; Katsunori Ueda; Takeshi Urabe
Journal:  Gan To Kagaku Ryoho       Date:  2004-03

Review 9.  Treatment of malignant pericardial effusion.

Authors:  P T Vaitkus; H C Herrmann; M M LeWinter
Journal:  JAMA       Date:  1994-07-06       Impact factor: 56.272

10.  Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).

Authors:  Kazuhiko Sato; Kenichi Inoue; Tsuyoshi Saito; Toshihiro Kai; Hiroyoshi Mihara; Katsuhiko Okubo; Junichi Koh; Hidetaka Mochizuki; Toshio Tabei
Journal:  Jpn J Clin Oncol       Date:  2003-08       Impact factor: 3.019

View more
  1 in total

Review 1.  Microtubule Inhibitors and Cardiotoxicity.

Authors:  Amogh M Joshi; George S Prousi; Christopher Bianco; Midhun Malla; Avirup Guha; Mahek Shah; Sherry-Ann Brown; Brijesh Patel
Journal:  Curr Oncol Rep       Date:  2021-02-13       Impact factor: 5.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.